retatrutide trial results news today Retatrutide, a new weight loss drug not available on the market yet, is showing promising in trials. Dr. LaPook explains it’s doing much more than what current medications can TRIUMPH-1 Trial Shows Potential for

10.1016/j.bpc.2017.06.006 Biophys Chem

Jens Juul Holst, a Danish GLP-1 expert at the University of Copenhagen, later recalled Engs frustration to Science magazine in 2018: He was extremely frustrated

34 For telehealth platforms, the goal is to be ready with a generic offering as soon as the innovators patent expires

Reduces Inflammation May help lower systemic inflammation, which can indirectly improve symptoms in some autoimmune conditions

We know next to nothing about how these drugs may be impacting people with higher levels of food restriction, which is risky considering how common these medications are and how easy it is to access them